Millendo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical stage
biopharmaceutical company primarily focused on developing novel
treatments for endocrine diseases with significant unmet needs,
announced today that Julia C. Owens, Ph.D., President and Chief
Executive Officer, will present at the 2020 Wedbush PacGrow
Healthcare Virtual Conference on Wednesday, August 12, 2020 at
12:35 p.m. EDT.
A live webcast of the presentation will be available on the
Investors & Media section of Millendo’s website at
http://investors.millendo.com. A replay of the webcast will be
archived on Millendo’s website for 30 days following the
About Millendo Therapeutics, Inc.
Millendo Therapeutics is a biopharmaceutical company primarily
focused on developing novel treatments for endocrine diseases where
current therapies do not exist or are insufficient. Millendo seeks
to create distinct and transformative treatments where there is a
significant unmet medical need. The company is currently advancing
MLE-301 for the treatment of vasomotor symptoms associated with
menopause. For more information, please visit www.millendo.com.
version on businesswire.com: https://www.businesswire.com/news/home/20200805005094/en/
Millendo Investor Contact: Connie Chang Millendo
Therapeutics 734-864-8006 firstname.lastname@example.org
Millendo Media Contact: Julie Bane MacDougall